What is Global Viscosupplementation for Knee Osteoarthritis Market?
The Global Viscosupplementation for Knee Osteoarthritis Market is a rapidly evolving sector that focuses on the treatment of knee osteoarthritis through viscosupplementation. This process involves injecting a gel-like substance, hyaluronic acid, into the knee joint to supplement the viscous properties of synovial fluid. This treatment aims to reduce pain, improve knee joint function, and potentially slow osteoarthritis progression. The market for this treatment is vast and diverse, encompassing various regions worldwide, with numerous key players contributing to its growth and development. The market's value is determined by the demand for this treatment, the number of people suffering from knee osteoarthritis, and the effectiveness of viscosupplementation in managing this condition.
Single Injection, Three Injection, Five Injection in the Global Viscosupplementation for Knee Osteoarthritis Market:
The Global Viscosupplementation for Knee Osteoarthritis Market is segmented based on the number of injections required for the treatment - single, three, and five injections. Single injection viscosupplementation is a one-time treatment that offers convenience and reduces the need for multiple hospital visits. However, its effectiveness may be shorter-lived compared to multiple injection regimens. Three-injection viscosupplementation involves administering three separate doses over several weeks, providing longer-lasting relief. Five-injection viscosupplementation, while more intensive, offers the longest duration of symptom relief. The choice between these options depends on various factors, including the patient's condition, preference, and the healthcare provider's recommendation.
Hospital Pharmacies, Retail Pharmacies in the Global Viscosupplementation for Knee Osteoarthritis Market:
The Global Viscosupplementation for Knee Osteoarthritis Market finds its application primarily in hospital pharmacies and retail pharmacies. Hospital pharmacies are typically where the viscosupplementation procedure is carried out, making them a significant segment of this market. These pharmacies procure and store the hyaluronic acid injections, ensuring their availability for the procedure. On the other hand, retail pharmacies play a crucial role in making these injections accessible to healthcare providers outside the hospital setting. They cater to the needs of patients who prefer to undergo the procedure in a non-hospital environment, such as a private clinic or at home.
Global Viscosupplementation for Knee Osteoarthritis Market Outlook:
The market outlook for the Global Viscosupplementation for Knee Osteoarthritis Market is promising. In 2023, the market was valued at a substantial US$ 1822.1 million. This value is expected to increase significantly, reaching an estimated US$ 2329.4 million by 2030. This growth, representing a Compound Annual Growth Rate (CAGR) of 3.6% from 2024 to 2030, indicates the increasing demand for viscosupplementation as a treatment for knee osteoarthritis. This growth can be attributed to factors such as the rising prevalence of knee osteoarthritis, advancements in viscosupplementation techniques, and increased awareness about this treatment option.
| Report Metric | Details |
| Report Name | Viscosupplementation for Knee Osteoarthritis Market |
| Accounted market size in 2023 | US$ 1822.1 million |
| Forecasted market size in 2030 | US$ 2329.4 million |
| CAGR | 3.6% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Sanofi, Anika Therapeutics, Seikagaku, Zimmer Biomet, Bioventus, Ferring, LG Chem, Freda, Haohai Biological, Shanghai Jingfeng |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
